The effect of febuxostat on diastolic function in hyperuricemic patients with LV diastolic dysfunction

Trial Profile

The effect of febuxostat on diastolic function in hyperuricemic patients with LV diastolic dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Sep 2015

At a glance

  • Drugs Febuxostat (Primary) ; Benzbromarone
  • Indications Hyperuricaemia; Left ventricular dysfunction
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Oct 2014 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 04 Apr 2014 Planned End Date changed from 30 Jun 2014 to 31 Aug 2014 as reported by University Hospital Medical Information Network - Japan.
    • 13 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top